Related Experiment Video
Updated: May 22, 2025

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Transient Thyroid Dysfunction in New-Onset Type 1 Diabetes: Reassessing Test Timing for Accurate Results
Talha Üstüntaş1, Mehmet Emre Atabek2, Beray Selver Eklioğlu2
1Department of Pediatrics, Necmettin Erbakan University, Konya, Türkiye.
Insights
Thyroid function in children with new-onset Type 1 diabetes mellitus (T1DM) often normalizes within two weeks. Immediate thyroid testing is recommended for those with existing thyroid disease or symptoms.
Area of Science:
- Pediatric Endocrinology
- Diabetology
- Thyroidology
Background:
- Type 1 diabetes mellitus (T1DM) is a common childhood endocrine disorder requiring comprehensive management.
- Thyroid dysfunction is a known comorbidity in T1DM patients.
- Understanding the temporal dynamics of thyroid function in newly diagnosed T1DM is crucial for appropriate clinical care.
Purpose of the Study:
- To determine the prevalence of thyroid dysfunction at diagnosis in pediatric T1DM patients.
- To investigate the long-term thyroid function status through periodic monitoring.
- To establish optimal timing for thyroid function testing in this population.
Main Methods:
- Retrospective cohort study of 208 pediatric patients with newly diagnosed T1DM.
- Analysis of medical records including demographics, clinical presentation, laboratory findings, and thyroid function tests.
- Periodic monitoring of thyroid function over time.
Main Results:
- Prevalence at diagnosis: 69.2% euthyroid, 24.5% euthyroid sick syndrome (ESS), 5.8% compensated hypothyroidism, 0.5% primary hypothyroidism.
- Significant improvement in thyroid function was observed between initial assessment and follow-up (P < .001).
- Approximately 76.5% of patients with initial ESS normalized thyroid function by the second visit, typically within 1-2 weeks.
Conclusions:
- Thyroid function tests in newly diagnosed T1DM pediatric patients should be conducted 1-2 weeks post-clinical stabilization.
- Immediate thyroid evaluation is warranted for T1DM patients with a history of thyroid disease or suggestive clinical signs.
- Periodic monitoring helps in understanding the transient nature of some thyroid function abnormalities in T1DM.
Abstract:
Objective: Type 1 diabetes mellitus (T1DM) is a prevalent chronic disease affecting children, necessitating ongoing care from multidisciplinary clinics. This study aimed to determine the prevalence of thyroid dysfunction in newly diagnosed T1DM patients, investigating long-term thyroid function through periodic monitoring. Materials and Methods: A retrospective cohort study utilized the medical records of pediatric patients with newly diagnosed T1DM. Extracted data included age at initial diagnosis, presenting clinical manifestations, standard laboratory findings, and thyroid function panel results. Results: The sample included 208 T1DM patients, with a higher proportion of males (54.8%) than females (45.2%). Initial assessment revealed that 69.2% of patients were euthyroid, 24.5% exhibited euthyroid sick syndrome (ESS), 5.8% compensated hypothyroidism, and 0.5% primary hypothyroidism. About 76.5% of patients initially diagnosed with ESS were euthyroid at the second visit. Analysis confirmed a significant difference in the distribution of euthyroid and ESS patients between the first and second visits (P < .001). Temporal analysis indicated that thyroid function tended to normalize within 1-2 weeks of the initial presentation. Conclusion: Tests should be performed within 1-2 weeks following clinical stabilization to evaluate thyroid function in newly diagnosed T1DM patients. However, patients with a history of thyroid disease, or those with clinical signs indicative of thyroid dysfunction, should undergo immediate testing at the time of diagnosis.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...

